JP2022554147A5 - - Google Patents

Info

Publication number
JP2022554147A5
JP2022554147A5 JP2022523874A JP2022523874A JP2022554147A5 JP 2022554147 A5 JP2022554147 A5 JP 2022554147A5 JP 2022523874 A JP2022523874 A JP 2022523874A JP 2022523874 A JP2022523874 A JP 2022523874A JP 2022554147 A5 JP2022554147 A5 JP 2022554147A5
Authority
JP
Japan
Prior art keywords
fingolimod
containing layer
treatment system
weight
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022523874A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022554147A (ja
JP7641279B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/079549 external-priority patent/WO2021078761A1/en
Publication of JP2022554147A publication Critical patent/JP2022554147A/ja
Publication of JP2022554147A5 publication Critical patent/JP2022554147A5/ja
Application granted granted Critical
Publication of JP7641279B2 publication Critical patent/JP7641279B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022523874A 2019-10-24 2020-10-21 フィンゴリモドの経皮投与のための経皮治療システム Active JP7641279B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19205133 2019-10-24
EP19205133.2 2019-10-24
PCT/EP2020/079549 WO2021078761A1 (en) 2019-10-24 2020-10-21 Transdermal therapeutic system for the transdermal administration of fingolimod

Publications (3)

Publication Number Publication Date
JP2022554147A JP2022554147A (ja) 2022-12-28
JP2022554147A5 true JP2022554147A5 (cg-RX-API-DMAC7.html) 2023-10-26
JP7641279B2 JP7641279B2 (ja) 2025-03-06

Family

ID=68342821

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022523874A Active JP7641279B2 (ja) 2019-10-24 2020-10-21 フィンゴリモドの経皮投与のための経皮治療システム

Country Status (8)

Country Link
US (1) US20230233480A1 (cg-RX-API-DMAC7.html)
EP (1) EP4048247B1 (cg-RX-API-DMAC7.html)
JP (1) JP7641279B2 (cg-RX-API-DMAC7.html)
CN (1) CN114599349B (cg-RX-API-DMAC7.html)
BR (1) BR112022007369A2 (cg-RX-API-DMAC7.html)
CA (1) CA3154505A1 (cg-RX-API-DMAC7.html)
ES (1) ES2980430T3 (cg-RX-API-DMAC7.html)
WO (1) WO2021078761A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024520271A (ja) * 2021-06-06 2024-05-24 スタートン セラピューティクス インコーポレイテッド 治療上有効な量のレナリドミドまたは他の免疫調節剤を投与するための経皮薬物送達システム

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387788B1 (en) * 2003-10-10 2008-06-17 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
KR101432698B1 (ko) 2006-06-06 2014-08-22 다우 코닝 코포레이션 실리콘 아크릴레이트 하이브리드 조성물
RU2544702C2 (ru) 2009-04-24 2015-03-20 Хенкель Корпорейшн Клеи на основе силикон-акрилового гибридного полимера
JP2013139554A (ja) 2011-11-29 2013-07-18 Dow Corning Corp シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法
CA2840997A1 (en) * 2013-02-05 2014-08-05 Nitto Denko Corporation Vaccine composition for transdermal administration
EP3054933A4 (en) * 2013-10-11 2017-03-15 Teikoku Pharma USA, Inc. Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same
KR102048682B1 (ko) 2015-02-09 2019-11-27 다우 실리콘즈 코포레이션 다중상 실리콘 아크릴 하이브리드 점탄성 조성물 및 이의 제조 방법
CN105395530A (zh) * 2015-11-27 2016-03-16 天津医科大学总医院 芬戈莫德的新用途
JP7071330B2 (ja) * 2016-07-27 2022-05-18 コリウム, インコーポレイテッド 炭酸水素ナトリウムのin situ変換で促進されたアミン薬物の経皮送達
KR102424270B1 (ko) 2016-07-27 2022-07-25 코리움, 인크. 경구 전달과 생물학적으로 동등한 약물동역학을 가진 경피 전달 시스템
EP3658127A1 (en) * 2017-07-26 2020-06-03 Corium, Inc. Transdermal delivery system with a microporous membrane having solvent-filled pores
US11229614B2 (en) * 2017-12-19 2022-01-25 The Johns Hopkins University Supramolecular hydrogel applications to the carotid bodies to treat hypertension and sleep apnea in obesity

Similar Documents

Publication Publication Date Title
CN1187049C (zh) 含有丁丙诺啡的贴片
US9717697B2 (en) Compositions and methods for the transdermal delivery of methylphenidate
JP2016502989A5 (cg-RX-API-DMAC7.html)
CA2423836A1 (en) Composition for the delivery of fentanyl
PL175083B1 (pl) Przezskórny układ terapeutyczny do podawania galantaminy na skórę
RU2014125322A (ru) Средство и способ трансдермальной доставки эстрогена
JP2010510260A5 (cg-RX-API-DMAC7.html)
JP2005528413A5 (cg-RX-API-DMAC7.html)
RU2004131866A (ru) Форма для трансэпикутального введения для лечения синдрома усталых ног
KR0163597B1 (ko) 니트로글리세린의 경피 투여형 약제
US4971799A (en) Percutaneous-administration-type pharmaceutical preparation of nitroglycerin
CN1655772A (zh) 含有芬太尼的贴剂
CA2275769A1 (en) Extremely flexible plaster acting dermally or transdermally, and method for producing same
JP2021522187A5 (cg-RX-API-DMAC7.html)
JP2021515789A5 (cg-RX-API-DMAC7.html)
JP5027373B2 (ja) エストラジオール含有貼付剤
JP2021515791A5 (cg-RX-API-DMAC7.html)
JP3676567B2 (ja) 医療用粘着剤組成物及び医療用貼付剤
EP1547600B1 (en) Estradiol-containing patch
KR100563194B1 (ko) 펜타닐을 유효성분으로 함유하는 경피투여제제
KR100579721B1 (ko) 툴로부테롤을 함유하는 경피투여용 패취제
KR20130049353A (ko) 펜타닐을 함유하는 경피투여용 패취시스템
JP4617069B2 (ja) 貼付剤
JP2021517569A5 (cg-RX-API-DMAC7.html)
AU2011248162A1 (en) Triamcinolone acetonide formulations for treating dermatitis and psoriasis